• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pembrolizumab-Induced Steroid-Responsive Myoclonus.帕博利珠单抗诱导的类固醇反应性肌阵挛
Mov Disord Clin Pract. 2022 May 3;9(4):546-550. doi: 10.1002/mdc3.13453. eCollection 2022 May.
2
Multiple Cranial Neuropathies Similar to Orbital Apex Syndrome Associated with Pembrolizumab: A Case Report.与帕博利珠单抗相关的类似眶尖综合征的多发性颅神经病变：一例报告
Case Rep Oncol. 2022 Oct 3;15(3):868-873. doi: 10.1159/000526901. eCollection 2022 Sep-Dec.
3
Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy-Review of the Literature and Future Outlook.与纳武单抗、伊匹单抗和帕博利珠单抗治疗相关的神经免疫相关不良事件——文献综述与未来展望
J Clin Med. 2019 Oct 24;8(11):1777. doi: 10.3390/jcm8111777.
4
Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer.病例报告：尼达尼布治疗非小细胞肺癌患者的帕博利珠单抗相关性肺炎
Front Oncol. 2021 Jun 18;11:673877. doi: 10.3389/fonc.2021.673877. eCollection 2021.
5
A Case of Melanoma-Associated Retinopathy, Uveitis, and Optic Neuritis Associated With Pembrolizumab, Managed With Topical, Intravitreal, and Intravenous Steroids.一例与帕博利珠单抗相关的黑色素瘤相关性视网膜病变、葡萄膜炎和视神经炎，采用局部、玻璃体内和静脉内类固醇治疗。
J Vitreoretin Dis. 2019 Nov 14;4(3):220-226. doi: 10.1177/2474126419886154. eCollection 2020 Jun.
6
Refractory Checkpoint Inhibitor Colitis Responsive to Ustekinumab.对优特克单抗有反应的难治性检查点抑制剂结肠炎
ACG Case Rep J. 2022 Dec 26;9(12):e00946. doi: 10.14309/crj.0000000000000946. eCollection 2022 Dec.
7
Myasthenia gravis with myositis induced by pembrolizumab therapy in a patient with metastatic urothelial carcinoma.帕博利珠单抗治疗转移性尿路上皮癌患者诱发重症肌无力合并肌炎
Int Cancer Conf J. 2020 Mar 21;9(3):123-126. doi: 10.1007/s13691-020-00408-4. eCollection 2020 Jul.
8
Isolated Abducens Nerve Palsy Following Pembrolizumab.帕博利珠单抗治疗后出现孤立性展神经麻痹。
Neuroophthalmology. 2019 Jan 16;44(3):182-185. doi: 10.1080/01658107.2019.1566385. eCollection 2020 Jun.
9
Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis: a case report.帕博利珠单抗诱发的重症肌无力样疾病、眼肌炎和肝炎：一例报告
J Med Case Rep. 2021 Apr 30;15(1):244. doi: 10.1186/s13256-021-02722-8.
10
Behcet's-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy.帕博利珠单抗治疗后出现的白塞氏病样综合征：一种与程序性死亡受体-1抑制剂治疗相关的免疫相关不良事件。
J Oncol Pharm Pract. 2020 Jun;26(4):995-999. doi: 10.1177/1078155219877219. Epub 2019 Oct 1.

引用本文的文献

1
Drug-Induced Myoclonus: A Systematic Review.药物性肌阵挛：一项系统评价
Medicina (Kaunas). 2025 Jan 15;61(1):131. doi: 10.3390/medicina61010131.
2
Autoimmune Movement Disorders Complicating Treatment with Immune Checkpoint Inhibitors.免疫检查点抑制剂治疗相关的自身免疫性运动障碍。
Mov Disord Clin Pract. 2024 May;11(5):543-549. doi: 10.1002/mdc3.14003. Epub 2024 Feb 23.

本文引用的文献

1
Neurological immune-related adverse events associated with immune checkpoint inhibitors: A review of the literature.免疫检查点抑制剂相关的神经免疫不良反应：文献复习。
Asia Pac J Clin Oncol. 2020 Dec;16(6):291-298. doi: 10.1111/ajco.13375. Epub 2020 Sep 7.
2
Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy-Review of the Literature and Future Outlook.与纳武单抗、伊匹单抗和帕博利珠单抗治疗相关的神经免疫相关不良事件——文献综述与未来展望
J Clin Med. 2019 Oct 24;8(11):1777. doi: 10.3390/jcm8111777.
3
Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity.磷酸二酯酶 10A 免疫球蛋白 G：副肿瘤性神经自身免疫的新型生物标志物。
Neurology. 2019 Aug 20;93(8):e815-e822. doi: 10.1212/WNL.0000000000007971. Epub 2019 Jul 17.
4
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.临床试验中 PD-1 和 PD-L1 抑制剂的治疗相关不良反应：系统评价和荟萃分析。
JAMA Oncol. 2019 Jul 1;5(7):1008-1019. doi: 10.1001/jamaoncol.2019.0393.
5
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial.帕博利珠单抗治疗难治或复发胸腺癌患者的开放性 II 期临床试验。
J Clin Oncol. 2019 Aug 20;37(24):2162-2170. doi: 10.1200/JCO.2017.77.3184. Epub 2018 Jun 15.
6
Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies.与抗程序性死亡1（PD-1）抗体相关的神经并发症
JAMA Neurol. 2017 Oct 1;74(10):1216-1222. doi: 10.1001/jamaneurol.2017.1912.
7
Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature.神经毒性：免疫检查点抑制剂治疗黑色素瘤的单一中心经验及文献复习
Ann Oncol. 2017 Feb 1;28(2):377-385. doi: 10.1093/annonc/mdw558.
8
Nivolumab-Induced Severe Akathisia in an Advanced Lung Cancer Patient.纳武利尤单抗致晚期肺癌患者严重静坐不能
Am J Case Rep. 2016 Nov 23;17:880-882. doi: 10.12659/AJCR.900941.

Pembrolizumab-Induced Steroid-Responsive Myoclonus.

作者信息

Gallagher Amy, Murphy Michael, McDermott Ray, Alexander Michael, O'Dowd Sean

机构信息

Department of Neurology Tallaght University Hospital Dublin Ireland.

Department of Medical Oncology Tallaght University Hospital Dublin Ireland.

出版信息

Mov Disord Clin Pract. 2022 May 3;9(4):546-550. doi: 10.1002/mdc3.13453. eCollection 2022 May.

DOI:10.1002/mdc3.13453
PMID:35586533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9092743/
Abstract
摘要